arrative Exposure Therapy for Posttraumatic Stress Disorder associated with repeated interpersonal trauma in patients with Severe Mental Illness: a mixed methods convergent desig

Completed

Conditions: schizofrenie en andere psychotische stoornissen, bipolaire stoornis, depressie, persoonlijkheidsstoornis
posttraumatic stress disorder (PTSD)
10002861

Registration Number: NL-OMON42436

Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 25

Inclusion Criteria

(1) SMI outpatients who receive NET and have one of the following primary diagnoses: schizophrenia (295.90), schizoaffective disorder (295.70), bipolar disorder type I (296.40-46 or 296.50-56), type II (296.89), major depressive disorder (296.20-26 or 296.30-36) according to M.I.N.I.-plus or personality disorder (301.xx) according SCID-II, and each has a GAF-score < 60 during >= two years.

Exclusion Criteria

(1) The provision of other trauma focused treatment in the past year, (2) the existence of a antisocial personality disorder, (3) the existence of a dissociative disorder, or (4) the provision of involuntary treatment following Mental Health Law.

Study & Design

Study Type: Observational non invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Quantitative parameters and outcomes:<br /><br>The existence of PTSD before and after providing NET according to CAPS-5<br /><br>Changes in: severity of PTSD and dissociative symptoms after providing NET<br /><br>according to CAPS-5 and DES.<br /><br>Changes in: primary disorder symptoms according to HoNOS, care needs according<br /><br>to CAN, quality of life according to MANSA, and care consumption in minutes<br /><br>before, during, and after NET treatment (retrieved from the electronic record).</p><br>

Secondary Outcome Measures